Maryland (GNP): Researchers funded by the U.S. National Institutes of Health (NIH) are investigating how high-fat diets may influence cancer-associated cachexia, a serious condition characterized by weight loss, muscle wasting, weakness, and other debilitating effects.
According to research highlighted by the NIH, scientists studying mice found that a high-fat diet strengthened signaling between certain lung tumors and the brain, potentially worsening the processes associated with cancer cachexia. Cachexia is a complex syndrome that can occur in people with advanced cancer, involving significant loss of body weight and muscle mass, often accompanied by weakness, fatigue and reduced appetite.
The latest findings add to growing scientific evidence that cancer-associated wasting is influenced not only by the tumor itself but also by interactions between tumors, the nervous system and the body’s metabolism. Recent research has identified communication between lung tumors and sensory nerves as an important pathway in cancer-associated cachexia. A 2026 study found that certain lung tumors can send signals through sensory neurons to the brain, contributing to sickness and wasting in experimental models.
Building on this, researchers have also found that high-fat diets can influence tumor-related wasting in experimental models. A separate 2026 study reported that high-fat diets and obesity increased muscle wasting, inflammatory signaling and tumor-cell proliferation in mice with experimental lung cancer.
These findings are significant because cachexia remains a major challenge in cancer care. Loss of muscle and other tissues can affect physical strength, quality of life and the body’s ability to tolerate treatment. However, the NIH-highlighted research should not be interpreted as evidence that a high-fat diet causes cancer cachexia in humans. The findings are based on experimental research, particularly studies involving mice, and further research is required to determine whether the biological mechanisms observed in animal models operate in the same way in people with lung cancer.
Scientists are increasingly examining the relationship between nutrition, metabolism, tumors and the nervous system in an effort to understand why some cancer patients experience severe wasting. One recent study published in Science found that a dietary intervention could influence tumor-derived signaling linked to cachexia in a mouse model. The researchers identified prostaglandin E2 (PGE2) and sensory-neuron signaling as important components of the process.
Also Read: UN Reaffirms Universal Commitment to Human Rights and Equality
These findings could eventually contribute to new approaches for managing cancer-associated cachexia. Potential future strategies may involve targeting the biological signals connecting tumors with the nervous system, alongside appropriate nutritional and medical care. Researchers caution, however, that cancer cachexia is biologically complex and may develop through different mechanisms depending on the type of tumor and individual patient.
The continuing research therefore represents an important step toward understanding a condition that has historically been difficult to treat. By examining how tumors interact with the brain, nerves, metabolism and nutrition, scientists hope to identify more effective ways to prevent or reduce muscle wasting and improve outcomes for patients living with cancer. For now, researchers emphasize that the evidence remains largely preclinical, and further human studies will be necessary before conclusions about dietary interventions or clinical treatment can be drawn.
